Day One Biopharmaceuticals (DAWN) Earnings Date & Reports
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
DAWN is expected to report earnings to rise 56.95% to -29 cents per share on March 09
Q4'25
Est.
$-0.30
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.07
Q4'24
Missed
by $0.17
The last earnings report on November 04 showed earnings per share of -18 cents, beating the estimate of -28 cents. With 5.14M shares outstanding, the current market capitalization sits at 908.16M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. DAWN showed earnings on November 04, 2025. You can read more about the earnings report here.